Treatment with Ramucirumab-paclitaxel in a metastatic gastric cancer patient undergoing hemodialysis: A case report

RATIONALE: Ramucirumab, a human Ig 1 monoclonal antibody against vascular endothelial growth factor receptor-2, in combination with paclitaxel is a second-line chemotherapy for patients with metastatic gastric cancer. Several reports have suggested that dose adjustments of cetuximab, an anti- epider...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Min Joo, Choi, Young Jin, Kim, Hyo Jeong, Kim, Do Young, Seol, Young Mi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2021
Materias:
5700
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7899881/
https://www.ncbi.nlm.nih.gov/pubmed/33607838
http://dx.doi.org/10.1097/MD.0000000000024795

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7899881/
https://www.ncbi.nlm.nih.gov/pubmed/33607838
http://dx.doi.org/10.1097/MD.0000000000024795

Ejemplares similares